Consequences of Abrupt Cessation of Alpha <sub>1</sub> -Antitrypsin Replacement Therapy
Oliver J. McElvaney, Tomás P. Carroll, Alessandro N. Franciosi, James Sweeney, Brian D. Hobbs, Vikita Kowlessar, Cedric Gunaratnam, Emer P. Reeves, Noel G. McElvaney
Abstract
Stopping Therapy for Alpha1-Antitrypsin Deficiency In Ireland, augmentation treatment of patients with genetic alpha1-antitrypsin deficiency was abruptly discontinued when government–industry price...
Topics & Concepts
Alpha 1-antitrypsin deficiencyAlpha (finance)MedicineInternal medicineSurgeryPatient satisfactionConstruct validityProtease and Inhibitor MechanismsBlood Coagulation and Thrombosis Mechanisms